These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 23873778

  • 1. Pretransplant donor-specific anti-HLA antibodies as predictors of early allograft rejection in ABO-compatible liver transplantation.
    Musat AI, Pigott CM, Ellis TM, Agni RM, Leverson GE, Powell AJ, Richards KR, D'Alessandro AM, Lucey MR.
    Liver Transpl; 2013 Oct; 19(10):1132-41. PubMed ID: 23873778
    [Abstract] [Full Text] [Related]

  • 2. Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation.
    Kanter Berga J, Sancho Calabuig A, Gavela Martinez E, Puig Alcaraz N, Beltran Catalan S, Avila Bernabeu A, Crespo Albiach J, Montoro JA, Pallardo Mateu LM.
    Transplant Proc; 2012 Nov; 44(9):2529-31. PubMed ID: 23146444
    [Abstract] [Full Text] [Related]

  • 3. Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation.
    O'Leary JG, Kaneku H, Jennings LW, Bañuelos N, Susskind BM, Terasaki PI, Klintmalm GB.
    Liver Transpl; 2013 Sep; 19(9):973-80. PubMed ID: 23780820
    [Abstract] [Full Text] [Related]

  • 4. Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts.
    Miyagawa-Hayashino A, Yoshizawa A, Uchida Y, Egawa H, Yurugi K, Masuda S, Minamiguchi S, Maekawa T, Uemoto S, Haga H.
    Liver Transpl; 2012 Nov; 18(11):1333-42. PubMed ID: 22888064
    [Abstract] [Full Text] [Related]

  • 5. Application of complement component 4d immunohistochemistry to ABO-compatible and ABO-incompatible liver transplantation.
    Salah A, Fujimoto M, Yoshizawa A, Yurugi K, Miyagawa-Hayashino A, Sumiyoshi S, Minamiguchi S, Uemoto S, Maekawa T, Haga H.
    Liver Transpl; 2014 Feb; 20(2):200-9. PubMed ID: 24470446
    [Abstract] [Full Text] [Related]

  • 6. Liver transplantation with a strongly positive crossmatch: case study and literature review.
    Leonard GR, Shike H, Uemura T, Gaspari JL, Ruggiero FM, Shah RA, Riley TR, Kadry Z.
    Liver Transpl; 2013 Sep; 19(9):1001-10. PubMed ID: 23798324
    [Abstract] [Full Text] [Related]

  • 7. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL, González-Escribano MF, González-Roncero FM, Acevedo-Calado MJ, Cabello-Chaves V, Gentil-Govantes MÁ, Núñez-Roldán A.
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [Abstract] [Full Text] [Related]

  • 8. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
    Kannabhiran D, Lee J, Schwartz JE, Friedlander R, Aull M, Muthukumar T, Campbell S, Epstein D, Seshan SV, Kapur S, Sharma VK, Suthanthiran M, Dadhania D.
    Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
    [Abstract] [Full Text] [Related]

  • 9. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R, O'Brien M, Hogan P, Thornton A, Fowler K, Byrne D, Stephens F, Harrocks S.
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [Abstract] [Full Text] [Related]

  • 10. Blood levels of donor-specific human leukocyte antigen antibodies after renal transplantation: resolution of rejection in the presence of circulating donor-specific antibody.
    Higgins R, Hathaway M, Lowe D, Lam F, Kashi H, Tan LC, Imray C, Fletcher S, Zehnder D, Chen K, Krishnan N, Hamer R, Briggs D.
    Transplantation; 2007 Oct 15; 84(7):876-84. PubMed ID: 17984841
    [Abstract] [Full Text] [Related]

  • 11. Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with chronic rejection and graft loss after liver transplantation.
    Kaneku H, O'Leary JG, Taniguchi M, Susskind BM, Terasaki PI, Klintmalm GB.
    Liver Transpl; 2012 Aug 15; 18(8):984-92. PubMed ID: 22508525
    [Abstract] [Full Text] [Related]

  • 12. Antibody-mediated rejection in ABO compatible husband to wife living donor liver transplant and review of the literature.
    Kheradmand T, Anthony TL, Harland RC, Testa G, Hart J, Renz J, Te HS, Marino SR.
    Hum Immunol; 2014 Jun 15; 75(6):578-83. PubMed ID: 24530823
    [Abstract] [Full Text] [Related]

  • 13. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
    Ali S, Ormsby A, Shah V, Segovia MC, Kantz KL, Skorupski S, Eisenbrey AB, Mahan M, Huang MA.
    Transpl Immunol; 2012 Jan 15; 26(1):62-9. PubMed ID: 21907804
    [Abstract] [Full Text] [Related]

  • 14. C4d-fixing capability of low-level donor-specific HLA antibodies is not predictive for early antibody-mediated rejection.
    Hönger G, Wahrmann M, Amico P, Hopfer H, Böhmig GA, Schaub S.
    Transplantation; 2010 Jun 27; 89(12):1471-5. PubMed ID: 20395886
    [Abstract] [Full Text] [Related]

  • 15. Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss.
    O'Leary JG, Kaneku H, Demetris AJ, Marr JD, Shiller SM, Susskind BM, Tillery GW, Terasaki PI, Klintmalm GB.
    Liver Transpl; 2014 Feb 27; 20(2):218-27. PubMed ID: 24382837
    [Abstract] [Full Text] [Related]

  • 16. Importance of human leukocyte antigen antibodies and leukocyte antigen/killer-cell immunoglobulin-like receptor genes in liver transplantation.
    Muro M, Legaz I.
    World J Gastroenterol; 2023 Feb 07; 29(5):766-772. PubMed ID: 36816626
    [Abstract] [Full Text] [Related]

  • 17. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
    Crespo M, Torio A, Mas V, Redondo D, Pérez-Sáez MJ, Mir M, Faura A, Guerra R, Montes-Ares O, Checa MD, Pascual J.
    Transpl Immunol; 2013 Dec 07; 29(1-4):28-33. PubMed ID: 23907088
    [Abstract] [Full Text] [Related]

  • 18. Anti-human leukocyte antigen immunization after early allograft nephrectomy.
    Del Bello A, Congy N, Sallusto F, Cardeau-Desangles I, Fort M, Esposito L, Guitard J, Cointault O, Lavayssière L, Nogier MB, Game X, Blancher A, Rostaing L, Kamar N.
    Transplantation; 2012 May 15; 93(9):936-41. PubMed ID: 22361471
    [Abstract] [Full Text] [Related]

  • 19. Donor-Specific Anti-HLA Antibodies and Endothelial C4d Deposition-Association With Chronic Liver Allograft Failure.
    Iacob S, Cicinnati VR, Lindemann M, Heinemann FM, Radtke A, Kaiser GM, Kabar I, Schmidt HH, Baba HA, Beckebaum S.
    Transplantation; 2015 Sep 15; 99(9):1869-75. PubMed ID: 25706274
    [Abstract] [Full Text] [Related]

  • 20. The severity of acute cellular rejection defined by Banff classification is associated with kidney allograft outcomes.
    Wu K, Budde K, Lu H, Schmidt D, Liefeldt L, Glander P, Neumayer HH, Rudolph B.
    Transplantation; 2014 Jun 15; 97(11):1146-54. PubMed ID: 24892962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.